chordoma rare slowgrowing neoplasm thought arise cellular remnants notochord evidence location tumors along neuraxis similar immunohistochemical staining patterns demonstration notochordal cells preferentially left behind clivus sacrococcygeal regions remainder notochord regresses fetal life laymans terms chordoma type spinal chordomas arise bone skull base anywhere along spine two common locations cranially clivus sacrum bottom sacral chordoma presented chronic low back small number families reported multiple relatives affected chordoma four families duplication brachyury gene found responsible causing possible association tuberous sclerosis complex first consensus guidelines diagnosis treatment chordoma published lancet tumors express brachyury cytokeratin detected immunohistochemistry three histological variants chordoma chondroid dedifferentiated cases complete surgical resection followed radiation therapy offers best chance longterm incomplete resection primary tumor makes controlling disease difficult increases odds recurrence decision whether complete incomplete surgery performed primarily depends anatomical location tumor proximity vital parts central nervous systemcitation needed chordomas relatively radioresistant requiring high doses radiation controlled proximity chordomas vital neurological structures brain stem nerves limits dose radiation safely delivered therefore highly focused radiation proton therapy carbon ion therapy effective conventional xray drugs currently approved treat chordoma however clinical trial conducted italy using tyrosine kinase inhibitor imatinib demonstrated modest response chordoma group italy found combination imatinib sirolimus caused response several patients whose tumors progressed imatinib alone erlotiniblike egfr inhibitors also reported effective although egfr mutation present chordoma egfr expression might predict response erlotinib shown report dr sameer report response olaparib one study tumor free survival rate sacral chordoma chondroid chordomas appear indolent clinical coursecitation needed united states annual incidence chordoma approximately one million new patients sacral chordomas make primary bone tumours primary sacral tumours thus making common malignant sacral tumour chordomas located sacrococcygeal region males aged years twice likely women get sacral currently known environmental risk factors chordoma noted germline duplication brachyury identified major susceptibility mechanism several chordoma people chordoma family members disease rare occurrences multiple cases within families documented suggests people may genetically predisposed develop chordoma genetic hereditary risk factors chordoma may exist scientists national cancer institute conducting familial chordoma study search genes involved development expert recommendations diagnosis treatment chordoma handbook produced chordoma foundation summarizes recommendations developed group leading doctors specialize caring chordoma patients available electronically english chinese italian dutch spanish hardcopies available english nfl player craig heyward treated chordoma ended career initially thought successfully removed tumor returned caused heywards death may needed pro skateboarder ray underhill member powellperalta bones brigade battled chordoma two years succumbing disease august needed cary tennis popular advice columnist salon announced column november diagnosed chordomacitation needed former spanish footballer jos√© enrique diagnosed chordoma may underwent surgery remove tumour june year announced april given clearcitation needed httpsenwikipediaorgwikichordoma